Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01403571 | Effectiveness and Safety of Salba on Weight Loss in Overweight Individuals With Type 2 Diabetes | PHASE2 | COMPLETED | 77 | — | — | Oct 1, 2009 | Aug 1, 2015 | Oct 5, 2016 | 1 | Canada |
24 week timeframe for Weightloss phase
| Arm | Type | Description |
|---|---|---|
| Salba supplement | EXPERIMENTAL | 30g/1000kal |
| Oat-bran based Control Supplement | PLACEBO_COMPARATOR | 36g/1000kcal |
| Name | Type | Description |
|---|---|---|
| Salba (Salvia hispanica L.) | DIETARY_SUPPLEMENT | 30g/1000kcal/day over 24 wks |
| Oat-based Control | DIETARY_SUPPLEMENT | Placebo: 36g/1000kcal/day over 24 weeks |
Inclusion Criteria: * Well-controlled type 2 diabetes for at least 1 year * Treated with diet and/or oral hypoglycemic medications * BMI 25-40 kg/m2 Exclusion Criteria: * Weight change in the past three months \>10% of body weight * On insulin therapy * Unstable angina, myocardial infarction or s...